RESOURCES & TOOLS
Sources of Pain
The U.S. National Library of Medicine’s MedlinePlus provides in-depth information on the different types of pain, treatment, and more.
Back Pain Guide by MedlinePlus
The U.S. National Library of Medicine’s MedlinePlus covers diagnosis, prevention, treatments, and more regarding back pain.
Complex Regional Pain Syndrome Guide by MedlinePlus
The U.S. National Library of Medicine’s MedlinePlus covers clinical trials, journal articles, and more regarding Complex Regional Pain Syndrome.
Peripheral Nerve Disorders Guide by MedlinePlus
The U.S. National Library of Medicine’s MedlinePlus covers symptoms, diagnosis, treatments and more regarding Peripheral Nerve Disorders.
Post Traumatic Stress Disorder Guide by MedlinPlus
The U.S. National Library of Medicine’s MedlinePlus covers diagnosis, coping mechanisms, treatments, and more regarding Post Traumatic Stress Disorder.
Carpal Tunnel Syndrome Guide by MedlinePlus
The U.S. National Library of Medicine’s MedlinePlus covers diagnosis, prevention, treatments and more regarding Carpal Tunnel Syndrome.
Drug Index
DEA Resource for Parents, Educators & Caregivers
Photos of drugs with their street names, use, associated paraphernalia, and more are provided by the DEA for accurate identification and education.
The National Institute on Drug Abuse provides a list of commonly abused drugs with detailed information on health risks, emerging trends, and more.
The U.S. National Library of Medicine’s MedlinePlus provides a thorough list of drugs, linking to in-depth information on their use, precautions, side effects, and more.
Risk Evaluation and Mitigation Strategies (REMS)
Opioids Required to Have an Opioid REMS
The U.S. Food and Drug Administration provides a list of extended-release and long-acting opioid products required to have an opioid REMS.
Extended-Release and Long-Acting Opioids
The U.S. Food and Drug Administration’s REMS program for extended-release and long-acting opioids hopes to reduce serious adverse outcomes from misuse and abuse of opioids.
Transmucosal Immediate Release Fentanyl (TIRF)
The U.S. Food and Drug Administration’s REMS program for Transmucosal Immediate Release Fentanyl (TIRF) hopes to reduce serious adverse outcomes from misuse and abuse of TIRF.
Transmucosal Immediate Release Fentanyl (TIRF) REMS Access Program
This FDA-required program is designed to ensure appropriate use of TIRF medicines while reducing the risk of misuse and other serious complications.
Tools for Proper Drug Use
The Washington State Agency Medical Directors’ Group provides an Opioid Dose Calculator that operates in real time and some quick links for more information on opioid dosing.
The National Institute on Drug Abuse shares the latest science, trends, statistics, and more related to addiction science.
Screening and Assessment Tools for Substance Use Disorders
The U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration developed this set of Screening and Assessment Tools to help address the problems that exist, the extent of those problems, and what actions should be taken to address them among those with substance use disorders.
Sample Opioid Treatment Agreement
The Sample Opioid Treatment Agreement, provided by the Washington State Department of Labor & Industries, clearly defines the relationship that should exist between patient, physician, and the prescribed medications, should one be treated with opioids. Side effects, risks, and responsibilities are all outlined so as to set expectations during treatment for chronic pain.
Drug Storage and Disposal
The National Community Pharmacists Association Foundation and the National Community Pharmacists Association designed a public service program to help connect people with independent community pharmacies where they can dispose of medicines safely.
National Prescription Drug Take Back Day
The U.S. Department of Justice and the Drug Enforcement Administration promote The National Prescription Drug Take Back Day on October 26 to provide safe and responsible means of disposing of prescription drugs.
The U.S. National Library of Medicine’s MedlinePlus publication provides information on the safe storage and disposal of medicines on page 8.
Other
The U.S. National Library of Medicine’s MedlinePlus offers information on toxicology screening.
Drug Interactions with Grapefruit Juice
The U.S. Food and Drug Administration explains why grapefruit juice can affect how some medicines perform and why this may result in dangerous side effects.
The National Institutes of Health provide education, wellness toolkits, and more on a wide variety of health issues.